refortan profile

refortan: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	34706
CHEMBL ID	1864088
SCHEMBL ID	503845
MeSH ID	M0077868

Synonyms (37)

Synonym
bis(4-chlorophenoxy)acetic acid
refortan
acetic acid, bis(p-chlorophenoxy)-
2-(bis(p-chlorophenyl)acetal)glyoxylic acid
acetic acid, bis(4-chlorophenoxy)-
einecs 249-874-7
glyoxylic acid, 2-(bis(p-chlorophenyl)acetal)-
brn 1887740
bis(p-chlorophenoxy)acetic acid
bc-9
bis(4-chlorophenoxy)acetic acid, 96%
NCGC00164413-01
AKOS001387785
2,2-bis(4-chlorophenoxy)acetic acid
zknszzxbpsicfk-uhfffaoysa-
inchi=1/c14h10cl2o4/c15-9-1-5-11(6-2-9)19-14(13(17)18)20-12-7-3-10(16)4-8-12/h1-8,14h,(h,17,18)
29815-94-9
A820061
4-06-00-00858 (beilstein handbook reference)
unii-of4f563p2r
of4f563p2r ,
SCHEMBL503845
CHEMBL1864088
ZKNSZZXBPSICFK-UHFFFAOYSA-N
acetic acid, 2,2-bis(4-chlorophenoxy)-
glyoxylic acid, 2-(bis(p-chlorophenyl) acetal)
DTXSID0040753
mfcd00004227
bis(4-chlorophenoxy)acetic acid, 99%
J-017656
FT-0751133
Z104483426
AMY25211
STR05304
Q27285623
CS-0077911
EN300-20833

Protein Targets (1)

Potency Measurements

Protein	Taxonomy	Measurement	Average (µ)	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
peroxisome proliferator activated receptor gamma	Homo sapiens (human)	Potency	50.1187	0.0010	19.4141	70.9645	AID588537
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (3)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	31.71 (24.57)
Research Supply Index	1.79 (2.92)
Research Growth Index	4.37 (4.65)
Search Engine Demand Index	35.06 (26.88)
Search Engine Supply Index	2.00 (0.95)

This Compound (31.71)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	5 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
urea pseudourea: clinical use; structure. isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.	2.08	1	0	isourea; monocarboxylic acid amide; one-carbon compound	Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite

Condition	Relationship Strength	Studies
Abdominal Injuries General or unspecified injuries involving organs in the abdominal cavity.	2.08	1
Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.	2.05	1
Nervous System Disorders [description not available]	2.03	1
Anesthesia A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.	2.03	1
Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.	2.03	1

refortan

Description